New Preventogen available soon!

Just published
NEW CLINICAL DATA highlighting the clinical success and efficacy of Preventogen, a new microbicidal liquid polymer for the reduction of pin-tract infections
Download Here
A revolutionary wound care polymer
In clinical studies, Preventogen has been shown to prevent infection and promote faster healing
Learn more
Protection from antibiotic resistant pathogens
Preventogen contains no antibiotics
Learn more
"Preventogen changed my life"
Mickele Williams, Preventogen patient with second degree burns
See my story
Previous
Next
FDA-CLEARED

Proven to kill the CDC's most serious threats

Preventogen has been proven to eradicate viruses, fungi and bacteria on contact

VIRUS

  • Herpes Simplex 1
  • Herpes Zoster

FUNGI

  • Aspergillus niger
  • T. rubrum
  • Candida albicans
  • D Aspergillus brasiliensis
  • Candida auris

BACTERIA

  • Escherichia coli​
  • Pseudomonas aeruginosa
  • Staphylococcus aureous
  • MRSA
  • VRE
  • Acinetobacter baumannii
  • Bacillus subtilis
  • Clostridium sporogenes​
  • Streptococcus pyogenes​

Preventogen provides non-antibiotic infection prevention

Kills all microbes

Eradicates all bacteria, fungi and viruses on contact​

Seals and Protects

Forms a biodegradable, water resistant protective barrier ​

Promotes faster healing

Optimizes the healing environment to help the body recover faster

Clinically proven protection from pin-tract infections

Preventogen showed a statistically significant reduction in pin-tract infections

(P < 0.001)

PREVENTOGEN

n=60
0 %

NO (0%) pin-tract infections

Control

n=60
0 %

14 (23%) pin-tract infections

Peer review
0 %

27% pin-tract infections**

**based on meta-analysis of 150 Peer Reviewed Clinical Studies

In the news

How Preventogen can affect COVID-19

Learn more